Append Medical is developing the Appligator™, a transcatheter device intended to completely close the left atrial appendage (LAA) without requiring any metal implants. The company plans to use recent funding to complete device development and to support a First‑in‑Human study of the Appligator™ for prevention of stroke in atrial fibrillation patients. Founded in 2018 by Dr. Zachi Berger based on an idea from Dr. Leonid Sternik of Sheba Medical Center, the company is led by CEO Nadav Agian. Append Medical is based in Or Yehuda, Israel, and is a portfolio company of the MEDX Xelerator incubator. The product positioning centers on offering a metal‑free alternative for LAA closure via a transcatheter procedure.

Total raised

$4M

Funding rounds

1

Latest round

Series A

Latest activity

Jul 2023